However, some researchers have reported that expression of ClC-3 is downregulated in IBD patients, which promotes intestinal epithelial cell apoptosis through the mitochondrial pathway, reduces the number of Paneth cells, and weakens expression of antimicrobial peptides to promote bacterial invasion of the mucosa [69]. The gene discussed is CLCN3; the disease is inflammatory bowel disease.